Global Advocacy

On 13 September 2018, COPD Global and the Global Asthma and Allergy Patient Platform (GAAPP) convened more than 35 stakeholders from around the globe in Paris, France for the first-ever Global Respiratory Summit. Participants included persons with chronic respiratory disease, caregivers and family members, nonprofit organization leaders, healthcare providers and industry partners. The one-day event was designed to introduce evolving best practices and stimulate discussion among attendees, leading to concrete action upon returning to home organizations. The three established objectives for the day were to:

  1. Share best practices. Attendees were encouraged to share both what is working in their roles as patient advocates and what lessons they have learned to inform the approaches of others.
  2. Build organizational capacity. Participants were asked to share tactics and resources that have enabled them to manage their organizations, expand their impact and measure their results.
  3. Leverage our collective voice. While more than one billion individuals are living internationally with chronic respiratory disease, we do not have the proportionate funding, surveillance data or attention these numbers demand. Attendees were called upon to work in disease-specific teams to determine discrete areas of focus and next steps to achieving goals in these areas.

Thank you to our sponsors AstraZeneca, GSK, Novartis and Sanofi/Regeneron without whose support this event would not have been possible.

Download PDF Global Report

COPD Global Advocates

COPD Global

For questions or information about COPD Global, please contact Sara Latham, Executive Vice President COPD Global, at